Anaplastic thyroid carcinoma: behavior, biology, and therapeutic approaches.
about
Cytotoxic effects of gemcitabine-loaded liposomes in human anaplastic thyroid carcinoma cellsInterventional bronchoscopy in the treatment of tracheal obstruction secondary to advanced thyroid cancer.Tumor-associated macrophages (TAMs) form an interconnected cellular supportive network in anaplastic thyroid carcinoma.Short course high dose radiotherapy in the treatment of anaplastic thyroid carcinomaChemotherapy for anaplastic thyroid cancer using docetaxel and cisplatin: report of eight casesPrognostic factors of anaplastic thyroid carcinoma.Poorly differentiated and anaplastic thyroid cancer.Protein kinase A-independent inhibition of proliferation and induction of apoptosis in human thyroid cancer cells by 8-Cl-adenosineAnaplastic thyroid carcinoma: three protocols combining doxorubicin, hyperfractionated radiotherapy and surgery.Recent progress of genome study for anaplastic thyroid cancer.Anaplastic Thyroid Carcinoma, Version 2.2015.Valproic Acid, a Histone Deacetylase Inhibitor, in Combination with Paclitaxel for Anaplastic Thyroid Cancer: Results of a Multicenter Randomized Controlled Phase II/III Trial.Anaplastic thyroid carcinoma: a 25-year single-institution experience.Carboplatin synergistically triggers the efficacy of photodynamic therapy via caspase 3-, 8-, and 12-dependent pathways in human anaplastic thyroid cancer cells.Anaplastic thyroid carcinoma: from clinicopathology to genetics and advanced therapies.Spanish consensus for the management of patients with anaplastic cell thyroid carcinoma.Intramedullary spinal cord metastasis arising from papillary thyroid carcinoma: A case report and review of literature.MicroRNAs in the thyroid.Rare diseases in clinical endocrinology: a taxonomic classification system.Tunicamycin enhances TRAIL-induced apoptosis by inhibition of cyclin D1 and the subsequent downregulation of survivin.Targeting thyroid cancer with acid-triggered release of doxorubicin from silicon dioxide nanoparticles.Selinexor (KPT-330) has antitumor activity against anaplastic thyroid carcinoma in vitro and in vivo and enhances sensitivity to doxorubicin.Immunosuppression involving increased myeloid-derived suppressor cell levels, systemic inflammation and hypoalbuminemia are present in patients with anaplastic thyroid cancer.A case report of "spinal cord apoplexy" elicited by metastatic intramedullary thyroid carcinoma.Time trend in tumour size and characteristics of anaplastic thyroid carcinoma.Refractory thyroid carcinoma: which systemic treatment to use?Fibrosis in undifferentiated (anaplastic) thyroid carcinomas: evidence for a dual action of tumour cells in collagen type I synthesis.A multimodality therapeutic approach in anaplastic thyroid carcinoma: study on 39 patients.Evidence from an updated meta-analysis of the prognostic impacts of postoperative radiotherapy and chemotherapy in patients with anaplastic thyroid carcinoma.
P2860
Q24793862-507420C9-C98B-4D31-A47E-BBF93F731305Q33239713-B40D8BC9-C49B-4D60-ABBA-B031A93B6690Q33980073-A7EDCD9A-5674-4D7E-9D63-01CE36A3E5E9Q34425352-60B26B23-49B9-473A-9DE2-B49E9A95EA47Q34946913-C82B8D89-3258-4837-9FC8-4D1523D6E498Q36428222-BCB6BDA1-6852-4ED9-8625-85C290435FF9Q36493228-F90F49F9-9ECF-4B06-BCB9-7A1FD1085FEBQ36494387-442DC20F-8295-4B03-B651-55DF0F008E2FQ36644686-5A65CF13-097C-47C5-9903-A7E62BD8CB94Q36992782-009E438C-67D3-415D-B8DB-2B410813A668Q37179204-DDEF0287-C229-4936-99B9-D9E077DE198DQ37330090-4DE1059D-017E-444E-B34A-D92FD1E41420Q38189700-98115723-6B3D-4906-820E-BEA280AC8C51Q38446206-CD9E1CA4-5258-4182-8F97-3B184AAF23DAQ38657760-A7DA8741-BD56-4F32-B2D8-078FCB332057Q38798863-AF12409D-9A0D-4FEB-B020-0B408F0C35E0Q38858695-52F0510D-82AD-4D45-9098-A6A25C93C2F5Q39030847-330E2B98-F75F-45E2-9DEB-66E5DE28B2E1Q39102141-6BAA7F80-83C6-485D-A16C-BDED6B0A2ED7Q39869215-7EA2476D-AB17-44C3-9BA7-9D0288221B88Q41532042-3BB87534-6C15-4EF5-A5A3-E320E4B34A4FQ41550563-061170D7-F915-4C0E-86F6-218D22FF13E1Q41920864-C41B66C5-9916-45D2-8CAE-EDEACA635637Q42205836-0B8B0A77-927E-4D73-A291-1DD246AEACB4Q47318825-8A14CC0F-C7C1-482A-B14A-E195A1EA8DB1Q49335901-C940A584-3881-4777-8DE5-C6D7BDFB46C9Q52831759-3E9EB02E-6759-47A8-B2EA-C066BDF8BE1CQ54020356-258DCDD6-E3E1-493A-9054-C2557D02E35FQ55018380-539B2F1F-E3FB-4523-920A-AF2BB7C9EB25
P2860
Anaplastic thyroid carcinoma: behavior, biology, and therapeutic approaches.
description
1998 nî lūn-bûn
@nan
1998年の論文
@ja
1998年学术文章
@wuu
1998年学术文章
@zh
1998年学术文章
@zh-cn
1998年学术文章
@zh-hans
1998年学术文章
@zh-my
1998年学术文章
@zh-sg
1998年學術文章
@yue
1998年學術文章
@zh-hant
name
Anaplastic thyroid carcinoma: behavior, biology, and therapeutic approaches.
@en
Anaplastic thyroid carcinoma: behavior, biology, and therapeutic approaches.
@nl
type
label
Anaplastic thyroid carcinoma: behavior, biology, and therapeutic approaches.
@en
Anaplastic thyroid carcinoma: behavior, biology, and therapeutic approaches.
@nl
prefLabel
Anaplastic thyroid carcinoma: behavior, biology, and therapeutic approaches.
@en
Anaplastic thyroid carcinoma: behavior, biology, and therapeutic approaches.
@nl
P356
P1433
P1476
Anaplastic thyroid carcinoma: behavior, biology, and therapeutic approaches.
@en
P2093
P304
P356
10.1089/THY.1998.8.715
P577
1998-08-01T00:00:00Z